LeonaBio Inc Sustainability Reports
A clinical-stage biopharmaceutical company focused on the development of novel small-molecule therapeutics for high unmet medical needs, including advanced breast cancer and amyotrophic lateral sclerosis (ALS).
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900CSS4S4X8VY5C81
1 reports from 2024 to 2024
Company Profile
A clinical-stage biopharmaceutical company focused on the development of novel small-molecule therapeutics for high unmet medical needs, including advanced breast cancer and amyotrophic lateral sclerosis (ALS).
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
